Compound heterozygosity

From WikiMD's WELLNESSPEDIA

(Redirected from Compound heterozygous)

Compound heterozygosity is a condition that occurs when an individual has inherited different forms of a particular gene from each parent. This can lead to various genetic disorders, depending on the specific genes involved.

Definition[edit]

Compound heterozygosity is a situation in which an individual has two different mutant alleles at a particular gene locus, one on each chromosome of a pair. The individual is a compound heterozygote, having inherited the different mutations from each parent. This is in contrast to a simple heterozygote, who has one mutant and one normal allele.

Genetic Disorders[edit]

Compound heterozygosity can lead to various genetic disorders. For example, it is a common cause of cystic fibrosis, a serious genetic disorder that affects the lungs and digestive system. Other disorders that can result from compound heterozygosity include sickle cell disease, thalassemia, and phenylketonuria.

Diagnosis[edit]

The diagnosis of compound heterozygosity typically involves genetic testing. This can include sequencing of the relevant gene, or more comprehensive genome sequencing. The results can then be used to determine the specific mutations present and their potential effects.

Treatment[edit]

The treatment for conditions resulting from compound heterozygosity depends on the specific disorder. For example, cystic fibrosis may be treated with medications to manage symptoms, physical therapy to improve lung function, and in some cases, lung transplantation.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.